Leading global Pharmaceutical, Biotechnology and Medical Device companies, as well as Contract and Medical Research Organizations turn to Ancillare to manage their clinical and ancillary supply and simplify Phase I-IV trial supply demands.


Leading Global Pharmaceutical, Biotechnology, and Medical Device companies, as well as Contract and Medical Research Organizations turn to Ancillare to manage their clinical ancillary supplies and equipment to simplify Phase I-IV trial supply demands.

Our History


In 2006, Ancillare took the first steps toward creating a first-of-its kind business: one that is wholly dedicated to the discipline of Clinical and Ancillary Supply Chain Management. Work began when a study sponsor challenged Ancillare to fix a critical business problem. The sponsor’s clinical project teams, already weighted by the important and difficult task of getting life-saving therapies to market, were also overwhelmed and distracted by the demands of sourcing, organizing and accounting for all the things necessary to do their work. The logistics of ancillary supply was, in a word, chaotic.

But worse than that, the process of managing ancillary supplies was costly. The sponsor was losing millions each day to the inefficiencies of running their supply chains the old-fashioned way.

Ancillare realized clinical trials needed a singular focus on the supply chain. And out of that need, Ancillare created a new category, which it called Clinical and Ancillary Supply Chain Management.


Ancillare, LP is founded in North Wales, PA.


The Ancillare Professional Team (APT) is formed to provide a dedicated management platform for clinical trial supply chain services for each sponsor organization.


Ancillare Global Headquarters established in Horsham, PA.


Ancillare Europe established in Milton Keynes, UK to service the EMEA region.

Ancillare establishes Strategic Depot in Canada.


The Ancillare Supply Chain Management System (ANSUMS™) is implemented, streamlining the process of ancillary product resupply and offering global visibility and reporting across the entire clinical pipeline.


Ancillare’s ESTEEM (Executing Shipments Through Effective Enrollment Monitoring) model is deployed. Resupply now matches site-specific patient enrollment rates, aligning distribution on demand.

Ancillare establishes Strategic Depots in Argentina, Brazil, Israel, Mexico, South America, South Korea and Ukraine.


Ancillare’s A-TKO first and only end-to-end clinical and ancillary supply chain model is introduced to ensure consistency, accuracy, and cost control throughout the development program lifecycle.

Ancillare Singapore is established in Singapore to service the APAC region.

Ancillare establishes Strategic Depots in China, Japan, Panama, Russia, and Taiwan.


Ancillare celebrates its 10th Anniversary.


Ancillare’s MedTech Division is established to service medical device and diagnostic trials.

Ancillare served as a key component in 1500 clinical trial in more than 100 countries across 80,000 clinical sites with more than 700,000 patients enrolled.

Ancillare expanded the Global Clinical Operations Department.


CEO Joanne Santomauro is recognized as an Ernst & Young Entrepreneur of the Year finalist.

CEO Joanne Santomauro is recognized as a Most Admired CEO honoree by the Philadelphia Business Journal.

President and Co-Founder Jonathan Santomauro is recognized as a 40 Under 40 honoree by the Philadelphia Business Journal.


8 of the Top 10 Global Pharmaceutical, 3 of the Top 5 Biotech companies and the Top 3 Global CROs employ Ancillare’s Clinical and Ancillary Supply Chain Management solutions.

Ancillare continues its singular, industry-leading mission as the global standard for Clinical and Ancillary Supply Chain Management.

A Singular Focus on Clinical and Ancillary Supply Chain

Ancillare is the only organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts.

Ancillare’s Turn-Key Operations (A-TKO) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Our Mission

At Ancillare, our mission is to maintain the integrity, quality and flow of the global pharmaceutical supply chain so our customers can focus on their mission to develop innovative therapies for patients.

Our Vision

As one of the leading partners providing clinical services today, Ancillare has built the experience, expertise and network necessary to ensure protocol success from start to finish. Headquartered near Philadelphia, PA (USA) we have successfully managed the global clinical and ancillary supply chain for sponsor organizations of all sizes and therapeutic areas.

Ancillare’s unique and dynamic clinical trials process management services include ancillary and clinical supplies management, regulatory compliance services and global logistics management. Each Ancillare Professional Team (APT™) provides the flexible staff augmentation necessary to service the largest and most complex modern protocols. Our services are supported by our customized ANSUMS™ system, which enhances process visibility and accountability across the supply chain.

Ancillare provides consistency and predictability in a global, decentralized system. Our end-to-end process management services are designed to help ensure protocol success, and our track record demonstrates our commitment to global excellence. Operating in more than 100 countries globally, Ancillare can manage the flow of supplies and equipment from start to finish, ensuring authenticity and efficiency to positively impact both local and global communities. Our goal is to lead the field in customized solutions for our partners, allowing them to produce the therapies needed to combat global illnesses.

Our Values


All Ancillare employees comply with the company’s ethics policy, code of conduct and local laws and regulations. We respect the privacy of employees and clients and the human rights of our global employees, partners, and vendor network.


We work together with our clients to understand and assess their needs and develop customized programs to meet their objectives.


We are invested in the global clinical supply chain. Our standards are a result of our ability to deliver superior solutions to our clients. We strive to constantly improve our processes and rise to any challenge presented in a protocol or in the field.


Our goal is to provide a robust supply chain to ensure protocol success. We work with our clients to develop innovative solutions to their problems and optimize processes, even if the solutions are absent in the marketplace today. We strive to exceed goals in every engagement and work to build the flexible programs needed for success.

Communicative & Transparent

We strive to create an open channel of communication with our partners at every step in the process. Information is the most valuable tool in any system, and our programs are designed to keep stakeholders informed and provide updates and notifications at every opportunity.


We work to build strategies based on the input of cross-functional teams. We leverage the combined experience and expertise of our teams to create action plans to meet the changing global environment. Our programs are designed to ensure open communication and collaboration within our company and with our clients and partners.

Social Responsibility

Ancillare believes we are an integral part of the global community. Socially responsible behavior provides long-term value to our clients, employees, partners, and the communities in which we live and work and is necessary for business sustainability and growth.

Our corporate culture demands that we act responsibly, complying fully with all applicable ethics policies, regulations and regulatory guidelines while ensuring all the work we do — from sourcing to distribution to destruction or reclamation — is conducted in a manner that is responsible to all the communities in which we operate.

Furthermore, individually and in teams, we participate in a variety of activities focused on children, underserved communities, health and animal welfare. Our employees regularly organize and host fundraising activities to raise awareness and funds to support these organizations, which include:

…and many more!


Contact Us Today for a Complimentary Clinical & Ancillary Supply Review